The purpose of our study was to evaluate the changes in clinical data, echocardiographic parameters, and NT-proBNP, as well as their associations with early cancer therapy-related LV dysfunction in breast cancer patients treated with anthracycline-based chemotherapy. Here, NPPB is linked to breast carcinoma.